- Home
- CNTA vs STAA Comparison
CNTA vs STAA Comparison
Compare CNTA & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTA
- STAA
- Stock Information
- Founded
- CNTA 2020
- STAA 1982
- Country
- CNTA United Kingdom
- STAA United States
- Employees
- CNTA N/A
- STAA N/A
- Industry
- CNTA Biotechnology: Pharmaceutical Preparations
- STAA Ophthalmic Goods
- Sector
- CNTA Health Care
- STAA Health Care
- Exchange
- CNTA Nasdaq
- STAA Nasdaq
- Market Cap
- CNTA 1.6B
- STAA 850.9M
- IPO Year
- CNTA 2021
- STAA N/A
- Fundamental
- Price
- CNTA $14.07
- STAA $17.86
- Analyst Decision
- CNTA Strong Buy
- STAA Hold
- Analyst Count
- CNTA 10
- STAA 8
- Target Price
- CNTA $28.78
- STAA $27.17
- AVG Volume (30 Days)
- CNTA 1.2M
- STAA 814.8K
- Earning Date
- CNTA 08-12-2025
- STAA 08-06-2025
- Dividend Yield
- CNTA N/A
- STAA N/A
- EPS Growth
- CNTA N/A
- STAA N/A
- EPS
- CNTA N/A
- STAA N/A
- Revenue
- CNTA $15,000,000.00
- STAA $279,134,000.00
- Revenue This Year
- CNTA N/A
- STAA N/A
- Revenue Next Year
- CNTA N/A
- STAA $29.34
- P/E Ratio
- CNTA N/A
- STAA N/A
- Revenue Growth
- CNTA 118.88
- STAA N/A
- 52 Week Low
- CNTA $8.46
- STAA $13.50
- 52 Week High
- CNTA $19.09
- STAA $49.86
- Technical
- Relative Strength Index (RSI)
- CNTA 60.47
- STAA 54.37
- Support Level
- CNTA $12.74
- STAA $16.40
- Resistance Level
- CNTA $14.27
- STAA $17.24
- Average True Range (ATR)
- CNTA 0.66
- STAA 0.66
- MACD
- CNTA 0.12
- STAA 0.12
- Stochastic Oscillator
- CNTA 85.57
- STAA 90.83
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.